HAP Trading’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-14,000
| Closed | -$24K | – | 1108 |
|
|
2023
Q1 | $24K | Sell |
14,000
-25,700
| -65% | -$7.11M | ﹤0.01% | 694 |
|
|
2022
Q4 | $286K | Buy |
39,700
+14,600
| +58% | +$4.12M | 0.03% | 395 |
|
|
2022
Q3 | $479K | Buy |
25,100
+5,800
| +30% | +$1.23M | 0.03% | 370 |
|
|
2022
Q2 | $1.12M | Buy |
19,300
+2,300
| +14% | +$470K | 0.06% | 269 |
|
|
2022
Q1 | $1.03M | Sell |
17,000
-16,800
| -50% | -$3.65M | 0.04% | 345 |
|
|
2021
Q4 | $1.05M | Buy |
33,800
+600
| +2% | +$154K | 0.03% | 463 |
|
|
2021
Q3 | $769K | Sell |
33,200
-6,400
| -16% | -$2.1M | 0.03% | 542 |
|
|
2021
Q2 | $495K | Sell |
39,600
-500
| -1% | -$151K | 0.02% | 648 |
|
|
2021
Q1 | $583K | Sell |
40,100
-17,300
| -30% | -$4.67M | 0.03% | 444 |
|
|
2020
Q4 | $1.52M | Buy |
57,400
+41,000
| +250% | +$10.6M | 0.04% | 320 |
|
|
2020
Q3 | $311K | Sell |
16,400
-1,400
| -8% | -$390K | 0.02% | 514 |
|
|
2020
Q2 | $395K | Buy |
17,800
+700
| +4% | +$210K | 0.02% | 493 |
|
|
2020
Q1 | $299K | Sell |
17,100
-200
| -1% | -$60.7K | 0.02% | 445 |
|
|
2019
Q4 | $286K | Sell |
17,300
-75,800
| -81% | -$21M | 0.02% | 400 |
|
|
2019
Q3 | $291K | Buy |
93,100
+80,100
| +616% | +$18.7M | 0.02% | 423 |
|
|
2019
Q2 | $187K | Buy |
13,000
+3,100
| +31% | +$716K | 0.01% | 505 |
|
|
2019
Q1 | $252K | Buy |
+9,900
| New | +$3.12M | 0.02% | 406 |
|
|
2018
Q4 | – | Sell |
-12,600
| Closed | -$52K | – | 1133 |
|
|
2018
Q3 | $52K | Buy |
+12,600
| New | +$4.34M | ﹤0.01% | 620 |
|
|
2018
Q2 | – | Sell |
-7,900
| Closed | -$239K | – | 985 |
|
|
2018
Q1 | $239K | Sell |
7,900
-9,600
| -55% | -$2.98M | 0.01% | 427 |
|
|
2017
Q4 | $165K | Buy |
17,500
+2,900
| +20% | +$930K | 0.01% | 523 |
|
|
2017
Q3 | $138K | Sell |
14,600
-38,000
| -72% | -$11.3M | 0.01% | 540 |
|
|
2017
Q2 | $296K | Buy |
52,600
+900
| +2% | +$238K | 0.02% | 447 |
|
|
2017
Q1 | $540K | Buy |
51,700
+38,100
| +280% | +$10.8M | 0.03% | 326 |
|
|
2016
Q4 | $219K | Sell |
13,600
-126,000
| -90% | -$37.3M | 0.01% | 458 |
|
|
2016
Q3 | $333K | Buy |
139,600
+117,700
| +537% | +$34.9M | 0.01% | 424 |
|
|
2016
Q2 | $222K | Sell |
21,900
-12,800
| -37% | -$3.37M | 0.01% | 421 |
|
|
2016
Q1 | $2.79M | Sell |
34,700
-93,700
| -73% | -$24.8M | 0.2% | 98 |
|
|
2015
Q4 | $5M | Sell |
128,400
-1,000
| -0.8% | -$287K | 0.24% | 88 |
|
|
2015
Q3 | $7.46M | Buy |
129,400
+115,300
| +818% | +$38.1M | 0.39% | 55 |
|
|
2015
Q2 | $125K | Buy |
14,100
+2,700
| +24% | +$1.08M | 0.01% | 543 |
|
|
2015
Q1 | $19K | Sell |
11,400
-15,000
| -57% | -$5.91M | ﹤0.01% | 724 |
|
|
2014
Q4 | $84K | Buy |
26,400
+5,800
| +28% | +$1.88M | ﹤0.01% | 656 |
|
|
2014
Q3 | $127K | Buy |
20,600
+6,600
| +47% | +$2.18M | 0.01% | 646 |
|
|
2014
Q2 | $150K | Buy |
14,000
+2,000
| +17% | +$602K | 0.01% | 602 |
|
|
2014
Q1 | $265K | Buy |
+12,000
| New | +$3.81M | 0.01% | 566 |
|
Other funds holding BIIB
HAP Trading's BIIB Position: Q1 2023 in Review
HAP Trading sold out of Biogen (BIIB) in Q1 2023, closing a stake of 27,549 shares — an estimated $7.62M sold.
HAP Trading first reported a position in BIIB in Q1 2014 and held it in 18 quarters. The position peaked at $30.2M in Q4 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.
- HAP Trading reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
- HAP Trading sold 27,549 Biogen shares in Q1 2023, an estimated $7.62M.
- HAP Trading first reported a position in Biogen in Q1 2014 and held it in 18 quarters.
- HAP Trading's Biogen position peaked at $30.2M in Q4 2015.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2023.
Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.